Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% return over the ...

Shares of Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from ...

Surgery Partners receives takeover bid from Bain Capital at $25.75 per share, sparking interest among potential buyers in the ...

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

Surgery Partners (NASDAQ:SGRY) soared 20% in premarket trading after it received a $25.75 a share non-binding offer from Bain Capital Private Equity. Bain Capital Private Equity made the offer on ...

With private equity circling and a modest premium on the table, will Bain's offer be enough to close the deal?

Surgery Partners (SGRY) announced that its board received a non-binding proposal, dated January 27, from Bain Capital Private Equity to acquire ...

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...